NL7204422A - - Google Patents

Info

Publication number
NL7204422A
NL7204422A NL7204422A NL7204422A NL7204422A NL 7204422 A NL7204422 A NL 7204422A NL 7204422 A NL7204422 A NL 7204422A NL 7204422 A NL7204422 A NL 7204422A NL 7204422 A NL7204422 A NL 7204422A
Authority
NL
Netherlands
Application number
NL7204422A
Other versions
NL175174B (nl
NL175174C (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to NLAANVRAGE7204422,A priority Critical patent/NL175174C/xx
Priority to ZA731921A priority patent/ZA731921B/xx
Priority to US00342338A priority patent/US3842064A/en
Priority to AU53578/73A priority patent/AU470906B2/en
Priority to GB1353373A priority patent/GB1429195A/en
Priority to CA167,350A priority patent/CA1025440A/en
Priority to DK171673A priority patent/DK145665C/da
Priority to DE2315826A priority patent/DE2315826C2/de
Priority to CH454573A priority patent/CH591429A5/xx
Priority to BE129515A priority patent/BE797612A/xx
Priority to JP48036611A priority patent/JPS5747666B2/ja
Priority to HUAO356A priority patent/HU169158B/hu
Priority to FR7311621A priority patent/FR2182918B1/fr
Priority to SE7304520A priority patent/SE392613B/xx
Publication of NL7204422A publication Critical patent/NL7204422A/xx
Publication of NL175174B publication Critical patent/NL175174B/xx
Application granted granted Critical
Publication of NL175174C publication Critical patent/NL175174C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C07K14/6955—Corticotropin [ACTH] with at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NLAANVRAGE7204422,A 1972-03-31 1972-03-31 Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden. NL175174C (nl)

Priority Applications (14)

Application Number Priority Date Filing Date Title
NLAANVRAGE7204422,A NL175174C (nl) 1972-03-31 1972-03-31 Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.
ZA731921A ZA731921B (en) 1972-03-31 1973-03-19 Psychopharmacologically active peptides
US00342338A US3842064A (en) 1972-03-31 1973-03-19 Psychopharmacologically active tetra-,penta-,hexa-,and hepta-peptides
AU53578/73A AU470906B2 (en) 1972-03-31 1973-03-21 Psychopharmacological peptides
GB1353373A GB1429195A (en) 1972-03-31 1973-03-21 Psychopharmacologically active peptides
CA167,350A CA1025440A (en) 1972-03-31 1973-03-28 Psychopharmacologically active peptides
DK171673A DK145665C (da) 1972-03-31 1973-03-29 Analogifremgangsmaade til fremstilling af et peptid eller funktionelle derivater heraf
DE2315826A DE2315826C2 (de) 1972-03-31 1973-03-29 Peptide und deren Derivate sowie diese Verbindungen enthaltende Arzneimittel mit psychopharmakologischer Wirkung
CH454573A CH591429A5 (cg-RX-API-DMAC7.html) 1972-03-31 1973-03-29
BE129515A BE797612A (fr) 1972-03-31 1973-03-30 Peptides et leurs derives a action psychopharmacologique
JP48036611A JPS5747666B2 (cg-RX-API-DMAC7.html) 1972-03-31 1973-03-30
HUAO356A HU169158B (cg-RX-API-DMAC7.html) 1972-03-31 1973-03-30
FR7311621A FR2182918B1 (cg-RX-API-DMAC7.html) 1972-03-31 1973-03-30
SE7304520A SE392613B (sv) 1972-03-31 1973-03-30 Forfarande for framstellning av peptider med psykofarmakologiska egenskaper

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NLAANVRAGE7204422,A NL175174C (nl) 1972-03-31 1972-03-31 Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.

Publications (3)

Publication Number Publication Date
NL7204422A true NL7204422A (cg-RX-API-DMAC7.html) 1973-10-02
NL175174B NL175174B (nl) 1984-05-01
NL175174C NL175174C (nl) 1984-10-01

Family

ID=19815760

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7204422,A NL175174C (nl) 1972-03-31 1972-03-31 Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.

Country Status (13)

Country Link
US (1) US3842064A (cg-RX-API-DMAC7.html)
JP (1) JPS5747666B2 (cg-RX-API-DMAC7.html)
BE (1) BE797612A (cg-RX-API-DMAC7.html)
CA (1) CA1025440A (cg-RX-API-DMAC7.html)
CH (1) CH591429A5 (cg-RX-API-DMAC7.html)
DE (1) DE2315826C2 (cg-RX-API-DMAC7.html)
DK (1) DK145665C (cg-RX-API-DMAC7.html)
FR (1) FR2182918B1 (cg-RX-API-DMAC7.html)
GB (1) GB1429195A (cg-RX-API-DMAC7.html)
HU (1) HU169158B (cg-RX-API-DMAC7.html)
NL (1) NL175174C (cg-RX-API-DMAC7.html)
SE (1) SE392613B (cg-RX-API-DMAC7.html)
ZA (1) ZA731921B (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7607684A (nl) * 1976-07-12 1978-01-16 Akzo Nv Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan.
US4180712A (en) * 1978-07-13 1979-12-25 Switchcraft, Inc. Slide switch
US4356119A (en) * 1978-09-28 1982-10-26 Nordisk Insulinlaboratorium Therapeutically active polypeptides or acid addition salts and a process for producing such compounds
FR2491922A1 (fr) 1980-10-14 1982-04-16 Roussel Uclaf Nouveaux hexapeptides, procede pour leur preparation et application comme medicaments
NL8101724A (nl) * 1981-04-08 1982-11-01 Akzo Nv Peptiden met zenuw-regenererende eigenschappen.
US4500713A (en) * 1982-09-23 1985-02-19 Usv Pharmaceutical Corporation Therapeutic dipeptides
US4623715A (en) * 1984-10-22 1986-11-18 Hoechst Aktiengeselleschaft Novel peptides which are active on the central nervous system and have an action on the cholinergic system
US5462927A (en) * 1985-04-30 1995-10-31 The Administrators Of The Tulane Educational Fund Peptides aiding nerve regeneration
DE3601398A1 (de) * 1986-01-18 1987-07-23 Fresenius Ag Verwendung von oligopeptiden zur behandlung von cerebralen stoerungen
DE3863027D1 (de) * 1987-08-14 1991-07-04 Akzo Nv Praeparat zur verhuetung oder bekaempfung von komplikationen bei diabetes.
DE3867039D1 (de) * 1987-11-11 1992-01-30 Akzo Nv Vincristin enthaltendes produkt.
JPH0230413U (cg-RX-API-DMAC7.html) * 1989-08-14 1990-02-27
ZA914684B (en) * 1990-07-18 1992-04-29 Akzo Nv Use of a centrally acting acth analog in the manufacture of a medicament
DE10241622A1 (de) 2002-09-04 2004-03-18 Takata-Petri Ag Airbageinheit für Kraftfahrzeuge
US20130059914A1 (en) 2010-04-21 2013-03-07 Signature Therapeutics, Inc. Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof
CN117715632A (zh) 2021-03-09 2024-03-15 恩赛斯生物科学股份有限公司 包含酶可裂解的前药和萘莫司他的组合物及其使用方法
KR20230174213A (ko) 2021-03-09 2023-12-27 엔사이스 바이오사이언시즈 인크. 나파모스타트의 변형된 방출 조성물 및 그의 사용 방법
MX2024003466A (es) 2021-09-29 2024-06-04 Ensysce Biosciences Inc Profarmacos de metadona escindibles por enzimas y metodos de uso de los mismos.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6509727A (cg-RX-API-DMAC7.html) * 1965-07-28 1967-01-30

Also Published As

Publication number Publication date
ZA731921B (en) 1973-12-19
FR2182918B1 (cg-RX-API-DMAC7.html) 1976-09-03
SE392613B (sv) 1977-04-04
DK145665C (da) 1983-07-18
DE2315826C2 (de) 1983-11-03
NL175174B (nl) 1984-05-01
BE797612A (fr) 1973-10-01
CH591429A5 (cg-RX-API-DMAC7.html) 1977-09-15
DK145665B (da) 1983-01-17
JPS4913168A (cg-RX-API-DMAC7.html) 1974-02-05
HU169158B (cg-RX-API-DMAC7.html) 1976-10-28
US3842064A (en) 1974-10-15
CA1025440A (en) 1978-01-31
FR2182918A1 (cg-RX-API-DMAC7.html) 1973-12-14
AU5357873A (en) 1974-09-26
NL175174C (nl) 1984-10-01
JPS5747666B2 (cg-RX-API-DMAC7.html) 1982-10-12
GB1429195A (en) 1976-03-24
DE2315826A1 (de) 1973-10-11

Similar Documents

Publication Publication Date Title
JPS5747666B2 (cg-RX-API-DMAC7.html)
JPS5725177B2 (cg-RX-API-DMAC7.html)
DE2236102B2 (cg-RX-API-DMAC7.html)
FR2175789B1 (cg-RX-API-DMAC7.html)
JPS4918019A (cg-RX-API-DMAC7.html)
JPS5611354Y2 (cg-RX-API-DMAC7.html)
JPS5237809B2 (cg-RX-API-DMAC7.html)
JPS491196U (cg-RX-API-DMAC7.html)
JPS4969461U (cg-RX-API-DMAC7.html)
JPS553878B2 (cg-RX-API-DMAC7.html)
JPS5729289B2 (cg-RX-API-DMAC7.html)
JPS4911006U (cg-RX-API-DMAC7.html)
CS154024B1 (cg-RX-API-DMAC7.html)
JPS4975560U (cg-RX-API-DMAC7.html)
CS152690B1 (cg-RX-API-DMAC7.html)
BG17928A1 (cg-RX-API-DMAC7.html)
CH257372A4 (cg-RX-API-DMAC7.html)
BG18223A1 (cg-RX-API-DMAC7.html)
BG17922A1 (cg-RX-API-DMAC7.html)
CH569197A5 (cg-RX-API-DMAC7.html)
CH563042A5 (cg-RX-API-DMAC7.html)
CH599224A5 (cg-RX-API-DMAC7.html)
NL7304630A (cg-RX-API-DMAC7.html)
CH594644A5 (cg-RX-API-DMAC7.html)
CH576991A5 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
V4 Lapsed because of reaching the maximum lifetime of a patent